Highest adjusted hazard ratios seen for anosmia, hair loss, sneezing, ejaculation difficulty, reduced libido
Europe Extends Locally Produced Monkeypox Vaccine Authorization
Denmark-based Bavarian Nordic A/S recently announced that the European Commission (EC) extended the marketing authorization for the Imvanex® smallpox vaccine to include protection from monkeypox and disease caused by the vaccinia virus.
The new EC approval is valid in all European Union Member States as well as in Iceland, Liechtenstein, and Norway.
Mobile Vaccinations Deliver Measurable ROI
Massachusetts General Hospital’s mobile COVID-19 vaccination van quadrupled its initial annual goal by providing more than 8,000 vaccinations within vulnerable communities impacted by the COVID-19 pandemic.
This innovative vaccination service focused on Chelsea, Revere, and Everett near Boston, MA, and was made possible by a $1 million donation from the CVS Health Foundation in partnership with the Kraft Center for Community Health and Mass General’s Center for Community Health Improvement.
Monkeypox Outbreak Declared Health Emergency of International Concern
The WHO Director-General Tedros Adhanom Gebreyesus today transmitted the Report of the second meeting of the International Health Regulations Emergency Committee regarding the multi-country outbreak of the monkeypox virus (MPXV).
The Director-General declared a Public Health Emergency of International Concern (PHEIC) based on various inputs.
He stated today that not determining a PHEIC would not mean “business as usual.”
Monkeypox is an Expanding Global Concern Impacting Everyone
Since early May 2022, cases of monkeypox virus disease have been reported from countries where the disease is not endemic, and continue to be reported in several endemic countries, says the World Health Organization (WHO).
This is the first time that monkeypox cases and clusters have been reported concurrently in non-endemic in widely disparate geographical areas worldwide.
Most confirmed monkeypox cases do not have travel histories to Africa, where the virus is endemic.
As of July 22, 2022, over eighty-five countries have reported about 17,388 cases.
Rate of COVID-19 Infection Higher in U.S. Youth Than Older Adults
Wild-type SARS-CoV-2 infection rates from beginning of pandemic through fall 2020 higher in adolescents, youth than in older adults
Simultaneous Flu Vaccine, COVID-19 Booster Safe
Systemic reactions generally mild, slightly more likely among those receiving both vaccines compared with COVID-19 mRNA booster alone
Biden Tests Positive for COVID-19
White House will provide a daily update on his condition ‘out of an abundance of transparency’
U.S. CDC Endorses Protein-Based COVID-19 Vaccine
The U.S. CDC Director Rochelle P. Walensky, M.D., M.P.H., announced her endorsement of the Advisory Committee on Immunization Practices (ACIP) recommendation that Novavax's COVID-19 Vaccine, Adjuvanted, become available as a primary two-dose series option for most adults.
Novavax's protein-based COVID-19 vaccine will be available in the USA soon. To date, the U.S. government has agreed to order 3.2 million doses of the Novavax vaccine under these existing agreements.
Yellow Fever Vaccine Coadministration Confirmed Safe for International Travelers
For international travelers to optimize an immune response from pre-departure vaccination, multiple factors such as the type of vaccine should be considered.
Another factor is the coadministration of multiple vaccines during a single appointment.
According to the U.S. CDC, most vaccines can be divided into two general categories: live or non-live.